
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES180
The ASCOT-LLA post hoc study290 found that among diabetic participants in the atorvastatin group, TC and LDL levels at year one of follow-up were lower than in the placebo group by ~1.3 and 1.2 mmol/l respectively. By the end of the study, these differences were 0.9 and 0.9 mmol/l respectively. However, no statistical analysis was performed. Level 1+

[@Poulter_2005]

